Report cover image

Hip Reconstruction Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Publisher GlobalData
Published Jun 13, 2024
Length 148 Pages
SKU # GBDT18983694

Description

Hip Reconstruction Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Hip Reconstruction Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Hip Reconstruction pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Hip Reconstruction or Hip Replacement is a procedure which involves replacement of the damaged or diseased parts of the hip joint. The Hip Reconstruction category includes devices (implants) used in the Hip Replacement procedures. A hip replacement is a common type of surgery where a damaged hip joint is replaced with an artificial one or an implant. Modern artificial hip joints are generally designed to last for 15 years or more.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Hip Reconstruction under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Hip Reconstruction and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Hip Reconstruction under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

148 Pages
    • Hip Reconstruction Overview
    • Hip Reconstruction - Pipeline Products by Stage of Development
    • Hip Reconstruction - Pipeline Products by Segment
    • Hip Reconstruction - Pipeline Products by Territory
    • Hip Reconstruction - Pipeline Products by Regulatory Path
    • Hip Reconstruction - Pipeline Products by Estimated Approval Date
    • Hip Reconstruction - Ongoing Clinical Trials
    • Hip Reconstruction Companies - Pipeline Products by Stage of Development
    • Hip Reconstruction - Pipeline Products by Stage of Development
    • 4WEB Medical Inc Company Overview
    • Arigin Medical Co Ltd Company Overview
    • Athroa Innovations Company Overview
    • Bactiguard Holding AB Company Overview
    • Beijing Ansong Technology Co Ltd Company Overview
    • BioPoly LLC Company Overview
    • Biotechni SAS Company Overview
    • Bonovo Orthopedics Inc Company Overview
    • Corin Group Ltd Company Overview
    • CytexOrtho Company Overview
    • DePuy Synthes Inc Company Overview
    • Dynamic Implant Inc Company Overview
    • Embody Orthopaedic Ltd Company Overview
    • Exactech Inc Company Overview
    • Flexable Orthopedics Company Overview
    • Fortis Orthopedics Company Overview
    • Fraunhofer Institute for Applied Polymer Research Company Overview
    • Gyder Surgical Pty Ltd Company Overview
    • Hip Innovation Technology LLC Company Overview
    • Implants International Ltd Company Overview
    • Inertial Orthopaedic Navigation Solutions (IONS) Pty Ltd Company Overview
    • Inor Medical Products Ltd Company Overview
    • JointMedica Ltd Company Overview
    • JRI Orthopaedics Ltd Company Overview
    • Lifespans Ltd Company Overview
    • Limacorporate SpA Company Overview
    • MicroPort Orthopedics Inc Company Overview
    • MicroPort Scientific Corp Company Overview
    • MX Orthopedics Corp Company Overview
    • Nano Interface Technology LLC (Inactive) Company Overview
    • Ortho Development Corp Company Overview
    • OrthoGrid Systems Inc Company Overview
    • Orthopaedic International Inc Company Overview
    • PreSRV Ltd. Company Overview
    • Pro-Dex Inc Company Overview
    • Renova Orthopedics LLC (Inactive) Company Overview
    • Rochester Institute of Technology Company Overview
    • SINTEF Company Overview
    • SINTX Technologies Inc Company Overview
    • Smith & Nephew Plc Company Overview
    • Stanford University Company Overview
    • University of Auckland Company Overview
    • University of Cincinnati Company Overview
    • University of Maine Company Overview
    • University of Oxford Company Overview
    • University of South Florida Company Overview
    • University of Southampton Company Overview
    • University of Warwick Company Overview
    • Zimmer Biomet Holdings Inc Company Overview
    • Jun 04, 2024: Medtronic Announces Dr. Goran Petrovski to Join Diabetes Medical Affairs Team
    • Jun 04, 2024: Medtronic Announces Retirement of Rob Ten Hoedt as Executive Vice President and President, Global Regions, Effective as of June 28, 2024
    • May 23, 2024: Orthofix Names Max Reinhardt President of Global Spine Business
    • May 08, 2024: Paragon 28 Reports First Quarter 2024 Financial Results and Reaffirms 2024 Net Revenue Guidance
    • May 06, 2024: Howmedica Osteonics Receives An Additional 510(k) Clearance For V40 Biolox Delta Ceramic Femoral Head
    • May 02, 2024: Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference
    • May 02, 2024: Zimmer Biomet Announces First Quarter 2024 Financial Results
    • Apr 28, 2024: MicroPort Orthopedics Receives Additional 510(K) Clearance For MPO Hip Instrument
    • Apr 25, 2024: Materialise Reports First Quarter 2024 Results
    • Apr 24, 2024: Stryker Receives Additional 510(k) Clearance for Hip System
    • Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer
    • Apr 23, 2024: MicroPort Orthopedics Receives 510(K) Clearance For Ceramic Femoral Head
    • Apr 23, 2024: Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
    • Apr 16, 2024: DePuy Ireland Receives Additional FDA 510(k) Clearance for Pinnacle Constrained Acetabular Liner
    • Apr 16, 2024: Orthofix Names Andres Cedron as New Chief Legal Officer
    • Apr 04, 2024: Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024
    • Mar 25, 2024: Howmedica Osteonics Receives FDA 510(k) Clearance for Modular Dual Mobility (MDM) X3 Insert For MDM Liner
    • Mar 18, 2024: Lucas Vitale Joins Orthofix as Chief People and Business Operations Officer
    • Mar 14, 2024: Ortho Development Receives FDA Clearance on Trivicta Hip System
    • Mar 13, 2024: Medacta Group Reports Robust Revenue Growth of 19.5% at Constant Currency and Adjusted EBITDA Margin 26.3%, or 27.9% at Constant Currency in FY 2023
    • Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
    • Feb 24, 2024: DePuy Ireland Receives 510(K) Clearance For EMPHASYS Dual Mobility System
    • Feb 22, 2024: Heraeus Medical Receives Additional 510(K) Clearance for COPAL Exchange G Hip Spacer
    • Feb 21, 2024: Orthofix Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call for March 5, 2024
    • Feb 17, 2024: Orchard Medical Development Receives 510(K) Clearance For Z1 Hip System
    • Feb 15, 2024: Reverse Hip Replacement System Unveiled at Global Orthopedic Surgery Meeting
    • Feb 14, 2024: Groundbreaking Innovation in Musculoskeletal Healthcare Takes Center Stage at AAOS 2024 Annual Meeting: CytexOrtho Named OrthoPitch Technology Competition Winner
    • Feb 13, 2024: HipInsight System Hits 3,000 Total Hip Replacement Case Milestone
    • Feb 12, 2024: Enovis to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
    • Feb 12, 2024: Smith+Nephew to Attend AAOS 2024 Annual Meeting
    • Feb 12, 2024: Orthopaedic Experts Identify Best Practices for Wound Closure and Dressing Management in Total Knee and Total Hip Arthroplasty
    • Jan 31, 2024: Stryker Corp Reports Strong Q4 and Full Year 2023 Results; Forecasts Continued Growth
    • Jan 29, 2024: DePuy Orthopaedics Receives Additional 510(K) Clearance For SUMMIT DuoFix Hip Prosthesis - MR Conditional
    • Jan 29, 2024: DePuy Orthopaedics Receives Additional 510(K) Clearance For SUMMIT Cemented Hip Prosthesis - MR Conditional
    • Jan 29, 2024: DePuy Orthopaedics Receives Additional 510(K) Clearance For SUMMIT FX Cemented Hip Prosthesis - MR Conditional
    • Jan 29, 2024: DePuy Ireland Receives Additional 510(K) Clearance For SUMMIT Basic Press-Fit Hip Prosthesis - MR Conditional
    • Jan 15, 2024: IMPLANET Reports 2023 Annual Revenue of 7.4 Million
    • Jan 11, 2024: Mount Carmel Health System and Anthem Announce Multi-Year Contract with Enhanced Value-Based Health Care and Improved Data Connectivity
    • Jan 09, 2024: Orthofix Medical Announces Preliminary 2023 Fourth Quarter and Full-Year Net Sales Results
    • Jan 08, 2024: Medacta's QUADRA-H hip stem achieves 13A exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP)
    • Jan 04, 2024: Serf Receives 510(K) Clearance For Novae Dual Mobility System
    • Jan 04, 2024: DePuy Ireland Receives 510(k) Clearance for CORAIL Cemented Femoral Stem
    • Jan 04, 2024: Stryker Obtains Additional 510(k) Clearance for Hip System
    • Jan 02, 2024: GYDER Surgical announces successful first surgical cases in India
    • Dec 12, 2023: Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics Company
    • Nov 28, 2023: AK Medical : Voluntary Announcement Certification by NMPA
    • Nov 08, 2023: Orthofix Reports Third Quarter 2023 Results
    • Nov 02, 2023: Implantcast Receives 510(K) Clearance For Actinia Hip Stem
    • Oct 26, 2023: 3D Printing Pioneer Materialise Appoints Brigitte de Vet-Veithen as New CEO
    • Oct 25, 2023: HSS Appoints New Leadership in Neurology and Anesthesia
    • Oct 11, 2023: DePuy Ireland Receives Additional 510(K) Clearance For TriFlange II Acetabular Cup System
    • Oct 09, 2023: Medacta International Receives Additional 510(k) Clearance for Mpact Extension
    • Oct 09, 2023: Stryker to Host Investor Day
    • Oct 05, 2023: Enovis to Showcase New Surgical Innovations at AAHKS Annual Meeting
    • Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
    • Oct 02, 2023: Stryker to Announce Financial Results for Its Third Quarter of Fiscal Year 2023
    • Sep 20, 2023: DePuy International Receives Additional 510(K) Clearance For Depuy 3D Additive Triflange Acetabular Cup
    • Sep 14, 2023: Smith & Nephew Brings BT Chief Financial Officer Simon Lowth to Board
    • Sep 14, 2023: New Non Executive Directors Join the Board at Med Tech Business
    • Sep 14, 2023: Smith & Nephew Announces Board Changes
    • Sep 12, 2023: Orthofix Announces Leadership Changes
    • Sep 05, 2023: Zimmer Biomet Announces Key Updates to Company's Executive Leadership Team
    • Aug 29, 2023: Luna Pathways Improves Postoperative Care: Patient Journey and Clinical Outcomes Outperform the Industry
    • Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
    • Aug 22, 2023: Zimmer Biomet Announces Leadership Transition
    • Aug 17, 2023: Smith+Nephew launches OR3O Dual Mobility System in India for use in primary and revision hip arthroplasty
    • Aug 16, 2023: Novel Combination of Oral Ketamine and Aspirin Is Safe Form of Pain Medication after Total Knee Replacement Surgery
    • Aug 09, 2023: Beijing Chunlizhengda Medical Instruments Co. Announces Annual Report for the Year Ended 31 December 2022
    • Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
    • Aug 07, 2023: Healthpoint celebrates milestone of 100 robotically assisted surgeries
    • Jul 28, 2023: Smith & Nephew Receives 510(K) Clearance for TANDEM Hip System
    • Jul 28, 2023: Medacta Group Announces 2023 Half-Year Unaudited Top-Line Figures
    • Jul 25, 2023: Limacorporate Receives Additional 510(K) Clearance for Minima S System
    • Jul 10, 2023: implantcast Receives 510(k) Clearance for BethaLoc Stem Cementless HA
    • Jul 05, 2023: Xerxes Arthopedix Receives 510(k) Clearance for Xerxes Hip Stem
    • Jun 28, 2023: Hip Innovation Technology Announces Positive Clinical Study Data of Its Novel Reverse Hip Replacement System for the Treatment of Total Hip Arthroplasty
    • Jun 22, 2023: Global Medical Technology Leader Zimmer Biomet Increases Presence in Malaysia With a New Office and GBS Center
    • Jun 16, 2023: Smith & Nephew Receives Additional 510(k) Clearance for ACCORD Cable System
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.